OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
37
Results
Show all
Save search
Copy query
Show results for
Unknown
(37)
Publication Date
Release Date
2021
(13)
2022
(11)
2024
(4)
2020
(4)
2025
(2)
2023
(2)
2019
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Sentinel surveillance for influenza A viruses in Lahore District Pakistan in flu season 2015-2016.
Not available
S-EPMC8734537
|
biostudies-literature
Cite
Evaluation of Cholinesterase Inhibitory Potential of Different Genotypes of
Ziziphus nummularia
, Their HPLC-UV, and Molecular Docking Analysis.
Not available
S-EPMC7663671
|
biostudies-literature
Cite
Clinical comparison of sub-mm high-resolution non-contrast coronary CMR angiography against coronary CT angiography in patients with low-intermediate risk of coronary artery disease: a single center trial.
Not available
S-EPMC8127202
|
biostudies-literature
Cite
COVID-19 vaccine acceptance in South Asia: a multi-country study.
Not available
S-EPMC8604279
|
biostudies-literature
Cite
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795
|
biostudies-literature
Cite
Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study).
Not available
S-EPMC9071082
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets